Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00459290 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

NETWORK

Sponsor class

Conditions

Fallopian Tube Cancer
Ovarian Cancer
Primary Peritoneal Cavity Cancer

Interventions

DRUG: mifepristone

Sponsor

Gynecologic Oncology Group